Millennium Management’s iHuman IH Stock Holding History

Millennium Management’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,226	Closed	-$24K	–	7198
2022 Q1	$24K	Sell	11,226 -3,268	-23%	-$7.82K	﹤0.01%	6600
2021 Q4	$41K	Buy	+14,494	New	+$62.2K	﹤0.01%	6515
2021 Q2	–	Sell	-29,671	Closed	-$371K	–	6760
2021 Q1	$371K	Sell	29,671 -16,979	-36%	-$300K	﹤0.01%	5069
2020 Q4	$845K	Buy	+46,650	New	+$1.04M	﹤0.01%	3839

Other funds holding IH

APA

Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's IH Position: Q2 2022 in Review

Millennium Management sold out of iHuman (IH) in Q2 2022, closing a stake of 11,226 shares — an estimated $24K sold.

Millennium Management first reported a position in IH in Q4 2020 and held it in 4 quarters. The position peaked at $845K in Q4 2020. 7 funds tracked by Wall St. Rank hold IH as of Q2 2022.

Millennium Management reported no remaining iHuman position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 11,226 iHuman shares in Q2 2022, an estimated $24K.
Millennium Management first reported a position in iHuman in Q4 2020 and held it in 4 quarters.
Millennium Management's iHuman position peaked at $845K in Q4 2020.
7 funds tracked by Wall St. Rank held iHuman as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.